Roivant Sciences Ltd. (ROIV) Debt to Equity Ratio
Roivant Sciences Ltd. (ROIV) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2022-03-31 | 0.14 |
| 2023-03-31 | 0.29 |
| 2024-03-31 | 0.01 |
| 2025-03-31 | 0.02 |
| 2026-03-31 | 0.02 |
Debt to equity divides total borrowings by total shareholder equity at the period end. Total borrowings are short-term debt plus long-term debt, including capital lease obligations. Non-debt liabilities such as accounts payable and deferred revenue are excluded. A period is omitted when equity is negative, because the ratio is not meaningful then.
Get Roivant Sciences Ltd. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("ROIV", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ROIV | $36.84 | -1.50% | 3.13M |
| 3 | ||||
| 4 | ||||
| 5 |